share_log

安迪苏(600299.SH):持续加强在合成生物学研究领域的合作

Andisu (600299.SH): Continuing to strengthen collaboration in synthetic biology research

Gelonghui Finance ·  May 9 16:50

Gelonghui, May 9丨Andy Su (600299.SH) said on an interactive platform that speeding up the development of the specialty products business is one of the keys to the “double pillar” strategy. By optimizing the layout of specialty products on a global scale, the company enhances the cost competitiveness, supply flexibility, customer response speed and level of sustainable development of specialty product supply. Every year, the company invests a large amount of R&D funds in the field of specialty products to ensure the launch of new specialty products and related services through various methods such as internal innovation and external strategic cooperation, while further developing and strengthening marketing products and services. Since 2014, the company has launched a new product/service every year, including new enzyme products, gut health products, etc. Feikang's single-cell products produced using innovative fermentation technology were successfully introduced to the market in April of this year. In addition, the company continues to strengthen cooperation in the field of synthetic biology research, such as establishing strategic partnerships with universities and research institutes such as Beijing University of Chemical Technology to strengthen Andisu's technical layout in the field of biotechnology and animal nutrition products, and promote the company to maintain ties with cutting-edge technology and seize possible industrialization opportunities.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment